Autres langues Noxopharm Limited

Actions

NOX

AU000000NOX9

Marché Fermé - Australian S.E. Autres places de cotation 05:57:59 02/05/2024			Varia. 5j.	Varia. 1 janv.
0,06 ^AUD	-11,76%		-6,25%	-15,49%

27/02	Noxopharm réduit sa perte nette au premier semestre fiscal malgré la baisse de l'incitation fiscale à la R&D	MT
26/02	Noxopharm Limited annonce ses résultats pour le semestre clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Noxopharm Receives AU$100,000 to Progress Brain Cancer Drug	04/04
Noxopharm Narrows Fiscal H1 Net Loss Despite Lower R&D Tax Incentive	27/02
Noxopharm Limited Reports Earnings Results for the Half Year Ended December 31, 2023	26/02
Noxopharm Extends Strategic Partnership with Hudson Institute of Medical Research	13/02
Noxopharm Receives AU$6.1 Million R&D tax Rebate; Shares Up 8%	16/11
Noxopharm talks partnership with Hudson Institute of Medical Research	12/10/23
Concerns of Further US Monetary Tightening Push Australian Shares to Nearly 11-Month Low	04/10/23
US FDA Grants Orphan Drug Status to Noxopharm's Pancreatic Cancer Drug; Shares Surge 73%	04/10/23
Noxopharm Validates Efficacy of Cancer Treatment in Animal Study; Shares Rally 13%	28/09/23
Noxopharm Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23
NobleOak Life Secures Approval from Financial Services Regulator for Reporting Standards	03/07/23
Noxopharm Limited Announces Change of Registered Office and Principal Place of Business	19/06/23
Study Finds Noxopharm's New SOF-XX Drug Reduces Inflammation	19/05/23
Noxopharm's NOXO Options to Expire June 18; Shares Down 17%	08/05/23
Noxopharm to Discontinue Veyonda Trials; to Focus on Chroma, Sofra Platforms; Shares Plummet 41%	06/04/23
Noxopharm to Develop Vaccine Enhancer; Shares Rise 3%	28/03/23
Noxopharm Limited Announces Novel mRNA Vaccine Enhancer	27/03/23
Noxopharm Limited Reports Earnings Results for the Half Year Ended December 31, 2022	24/02/23
Noxopharm Limited to Present Sofra Study at Lupus 2023 Conference	21/02/23
NobleOak Life to Release Shares from Voluntary Escrow	09/02/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Noxopharm Limited

Actions

NOX

AU000000NOX9

Autres langues

Filtres